FR3456M - Médicament a base de fluoropyrimidines. - Google Patents

Médicament a base de fluoropyrimidines.

Info

Publication number
FR3456M
FR3456M FR972534A FR972534A FR3456M FR 3456 M FR3456 M FR 3456M FR 972534 A FR972534 A FR 972534A FR 972534 A FR972534 A FR 972534A FR 3456 M FR3456 M FR 3456M
Authority
FR
France
Prior art keywords
fluoropyrimidines
based drug
drug
fluoropyrimidines based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR972534A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of FR3456M publication Critical patent/FR3456M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR972534A 1963-05-02 1964-04-28 Médicament a base de fluoropyrimidines. Active FR3456M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US277441A US3277092A (en) 1963-05-02 1963-05-02 5, 6-substituted dihydro-5-fluoropyrimidines

Publications (1)

Publication Number Publication Date
FR3456M true FR3456M (fr) 1965-07-26

Family

ID=23060875

Family Applications (2)

Application Number Title Priority Date Filing Date
FR972534A Active FR3456M (fr) 1963-05-02 1964-04-28 Médicament a base de fluoropyrimidines.
FR972727A Expired FR1396681A (fr) 1963-05-02 1964-04-29 Procédé pour la préparation de fluoropyrimidines

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR972727A Expired FR1396681A (fr) 1963-05-02 1964-04-29 Procédé pour la préparation de fluoropyrimidines

Country Status (8)

Country Link
US (1) US3277092A (fr)
BE (1) BE647322A (fr)
BR (1) BR6458768D0 (fr)
DE (1) DE1445894A1 (fr)
DK (1) DK105592C (fr)
ES (1) ES299417A1 (fr)
FR (2) FR3456M (fr)
GB (1) GB1006155A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954758A (en) * 1970-05-27 1976-05-04 Pcr, Inc. Process for fluorinating uracil and derivatives thereof
CA991178A (en) * 1971-10-04 1976-06-15 Geraldine Westmoreland 5-fluorouracil derivatives and process of producing 5-fluorouracil and derivatives thereof in aqueous solvents
US3954759A (en) * 1972-07-13 1976-05-04 Pcr, Inc. Process for preparation of 6-substituted 5-fluorouracil derivatives
GR68935B (fr) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993039A (en) * 1959-11-06 1961-07-18 Upjohn Co Preparing nu-glycosides of aldose and ketose sugars

Also Published As

Publication number Publication date
DK105592C (da) 1966-10-17
BE647322A (fr) 1964-10-29
DE1445894A1 (de) 1969-01-16
US3277092A (en) 1966-10-04
FR1396681A (fr) 1965-04-23
GB1006155A (en) 1965-09-29
BR6458768D0 (pt) 1973-08-09
ES299417A1 (es) 1964-12-01

Similar Documents

Publication Publication Date Title
DK115947B (da) Vagitorium.
FR3681M (fr) Médicament a base de composés hétérocycliques.
DK105902C (da) Metalbor.
DK112351B (da) Sprøjteapparat.
FR3455M (fr) Médicament a base de nucléosides de fluoropyrimidines.
FR3826M (fr) Médicament fongicide.
FR3522M (fr) Médicament a base de benzamides substitués.
FR3456M (fr) Médicament a base de fluoropyrimidines.
DK107717C (da) Pattegummi.
NL148116B (nl) Weeflis.
FR3475M (fr) Médicament a base de diphényl-amino-éthylamine.
FR2831M (fr) Médicament a base de pancréas.
FR3202M (fr) Médicament a base de dérivé de théophylline.
DK133441B (da) Forbindelsesplade.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR3583M (fr) Médicament fongicide.
FR3755M (fr) Médicament a base de nouvelles pénicillines.
NL144671B (nl) Spindop.
FR3790M (fr) Nouveaux médicaments a base de 2-alkyl-4-alkylamino-6-alkoxy-s-triazines.
FR3162M (fr) Médicament a base de sulfapyrimidines.
FR3543M (fr) Médicaments a base de cétones basiques.
DK113039B (da) Stald.
DK116104B (da) Insecticid.
FR3512M (fr) Médicaments a base de 1-beta-d-arabinofuranosylcytosine.
FR3494M (fr) Médicament a base de 16α-méthyl-stéroides.